• Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
  • Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
  • Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
  • Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
  • Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
  • Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder

Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP, COA
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >96%
Samples:
US$ 26/kg 1 kg(Min.Order)
| Request Sample
Customization:
Gold Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Function
  • Hot Products
  • Company Profile
  • Packaging & Shipping
Overview

Basic Info.

Model NO.
HMJ-Ulipristal Acetate
Model No.
Hmj-Mexidol Hydrochloridefenspiride Hydrochlorideu
Product Name
Ulipristal Acetate Powder
Appearance
White Fine Powder
Certificate
GMP ISO USP Bp
Assay
99% Min
Test
HPLC
CAS
5053-08-7
Sample
Ulipristal Acetate Avaliable
Transport Package
Foil Bag. Drum
Specification
1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
Trademark
HMJ
Origin
China
HS Code
2932209090
Production Capacity
200kg/Month

Product Description

Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
Product Description

 

Name Ulipristal Acetate
CAS NO 126784-99-4
EINECS 682-170-1
Molecular Formula C30H37NO4
Molecular Weight 475.619
Density 1.2±0.1 g/cm3
Boiling Point 640.1±55.0°C at 760 mmHg
Melting Point 183-185°C
Flash Point 340.9±31.5°C
PSA 63.68000
LogP 4.48
pka 5.49±0.24(Predicted)
Storage Temp  -20°C
Package Drum / Aluminum Foil Bag / According to customer's requiement
Function

 

Description:

Ulipristal acetate  is the first of a new class of selective progesterone receptor modulators, and is indicated for emergency contraception within 120 hours after unprotected sexual intercourse or contraceptive failure. The principal effect of ulipristal acetate is to inhibit or delay ovulation. This effect may result from the drug's ability to delay the onset of  (LH) surge or postpone LH peak if LH surge has started, or possibly by a direct inhibitory effect on follicular rupture, when administered in the follicular phase (including just before ovulation). In clinical trials, a single oral dose of ulipristal acetate 30 mg was effective in preventing pregnancies in women requesting emergency contraception after unprotected sexual intercourse and provided sustained efficacy throughout the 120-hour postcoital period in which it is indicated.


 
  • FDA Approved Novel Emergency Contraception  within 120 hours of unprotected sexual intercourse
  • Reduce the size of the fibroids before the surgery
  • Ulipristal acetate for uterine fibroids
Hot Products

 

 Supply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
Company Profile

 

Supply Pharmaceutical Raw Material Pure Ulipristal Acetate PowderSupply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
Packaging & Shipping

 

Supply Pharmaceutical Raw Material Pure Ulipristal Acetate PowderSupply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
Supply Pharmaceutical Raw Material Pure Ulipristal Acetate PowderSupply Pharmaceutical Raw Material Pure Ulipristal Acetate PowderSupply Pharmaceutical Raw Material Pure Ulipristal Acetate Powder
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now